Santa Clara University

Department of Chemistry & Biochemistry

Alumni

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
Alumnus/Alumna Information
Last                 Name (while at Santa Clara):
Vlahos
Last                 Name (if different now):
 
First                 Name:
Chris
Graduation                 Year:
1982
E-mail:
Vlahos_chris_j@lilly.com
 
Job Information
Job                 Title and Description:
Head, Atherosclerosis-Vascular               Wall Drug Discovery Team
Corporation/Institution:
Cardiovascular Research
              Eli Lilly and Company
Job City and State:
Indianapolis, IN 46285
   
Graduate and Professional Schools,               Degrees, Awards
MS, The University of Michigan, Ann Arbor               MI 1984
              PhD, The University of Michigan, Ann Arbor MI 1987
Biographical Information
Chris J. Vlahos, PhD is Head of the Atherosclerosis-Vascular               Wall Drug Discovery Team in the Cardiovascular Research Division               of Eli Lilly and Company in Indianapolis, Indiana. His research               interests include the development of inhibitors against cellular               signaling targets and the impact of the resulting inhibition on               signal transduction pathways. He received his BS (cum laude) in               Chemistry from Santa Clara University in 1982 and his Ph.D. from               the University of Michigan in the Department of Biological Chemistry               in 1987. Trained as a protein biochemist/enzymologist, he joined               Lilly Research Laboratories in 1986 as a Senior Biochemist in the               Molecular Biology Research Division, and has been in the Cardiovascular               Research Division since 1990. Dr. Vlahos established a screen for               inhibitors of PI 3-kinase, the result of which was his discovery               of LY294002. He is currently studying novel kinase and phosphatase               targets involved in the cellular mechanisms of cardiac and vascular               diseases.
Printer-friendly format
 

 

© 2013 Santa Clara University | Department of Chemistry & Biochemistry|
500 El Camino Real, Santa Clara, California 95053-0270 | 408-554-4799  | Fax: 408-554-7811 |
Contact us: l1barretto@scu.edu.